Seyed-Vahid Tabatabaei

  • Citations Per Year
Learn More
BACKGROUND Hepatitis C virus (HCV) infection is the most common transfusion-transmitted disease in multiply transfused patients worldwide. In this study, the aim was to investigate distribution of HCV genotypes in Iranian patients with thalassemia. STUDY DESIGN AND METHODS Blood samples were received from 280 multiply transfused patients with thalassemia(More)
Hepatitis C virus infection (HCV) is the major co-morbidity of patients on chronic hemodialysis. There are many scattered and heterogeneous data about this infection in hemodialysis patients living in countries of the Eastern Mediterranean Region Office of WHO (EMRO) and its distribution is unknown in this region. To provide a more comprehensive tabulation(More)
BACKGROUND/AIMS The distribution of blood lipids, glucose and their determinants in thalassemic patients with chronic hepatitis C virus (HCV) infection has rarely been investigated. Thus, we aimed to investigate the relationship between both liver histologic findings and viral markers and serum lipids in thalassemic patients chronically infected with HCV.(More)
history of chronic hepatitis C (genotype 1) with a liver biopsy in 2008, which revealed inflammation with fibrosis and no evidence of cirrhosis. Patient was initially treated with interferon monotherapy in 2000. Her treatment was discontinued because of a lack of viral response. Her course of treatment was complicated by alopecia of the scalp, which did not(More)
BACKGROUND Many patients receiving long-term dialysis do not produce protective antibodies to hepatitis B virus (HBV) surface antigen (HBsAg) after HBV vaccination. The results from several studies have suggested benefit of oral levamisole as an adjuvant to HBV vaccination in patients with end-stage renal disease (ESRD). However, reliable information is(More)
Dear Editor, We read with great interest the published letter by Taher et al. [1]. It was a case report of sustained viral response in retreatment of chronic hepatitis C virus (HCV) infection with pegylated interferon and ribavirin in a thalassemic case with previous combination treatment failure after switching to another iron chelating agent that(More)
  • 1